Follow @ai.nejm.org for medical AI content.
#MedSky
#MedSky
Evolocumab in Patients without Previous MI or Stroke (VESALIUS-CV trial) nej.md/4oWrIN6
Fish Oil, Cardiovascular Events, and Hemodialysis (PISCES trial) nej.md/49zWuqo
#MedSky
Evolocumab in Patients without Previous MI or Stroke (VESALIUS-CV trial) nej.md/4oWrIN6
Fish Oil, Cardiovascular Events, and Hemodialysis (PISCES trial) nej.md/49zWuqo
#MedSky
#MedSky #NeuroSky #PedSky
#MedSky #NeuroSky #PedSky
#MedSky #GastroSky
#MedSky #GastroSky
@i-med.ac.at #MedSky #DermSky
@i-med.ac.at #MedSky #DermSky
Challenge closing soon... Cast your vote now! nej.md/3Yfizns
#MedSky
Challenge closing soon... Cast your vote now! nej.md/3Yfizns
#MedSky
#MedSky #CardioSky
#MedSky #CardioSky
Explore the full issue: nej.md/4j0CAHN
Explore the full issue: nej.md/4j0CAHN
@ucsandiego.bsky.social #MedSky
@ucsandiego.bsky.social #MedSky
1️⃣ Universal Base-Edited CAR7 T Cells for T-Cell Acute Lymphoblastic Leukemia nej.md/48wiyQL
𝗡𝗼𝘁𝗮𝗯𝗹𝗲 𝗵𝗲𝗮𝗱𝗹𝗶𝗻𝗲:
Pioneering new treatment reverses incurable blood cancer in some patients (BBC) nej.md/497Tgdp
1️⃣ Universal Base-Edited CAR7 T Cells for T-Cell Acute Lymphoblastic Leukemia nej.md/48wiyQL
𝗡𝗼𝘁𝗮𝗯𝗹𝗲 𝗵𝗲𝗮𝗱𝗹𝗶𝗻𝗲:
Pioneering new treatment reverses incurable blood cancer in some patients (BBC) nej.md/497Tgdp
#MedSky #CardioSky
#MedSky #CardioSky
#MedSky #PedSky #Immunology
#MedSky #PedSky #Immunology
#MedSky #Hematology #GastroSky
#MedSky #Hematology #GastroSky
#MedSky #IDSky #Immunology
#MedSky #IDSky #Immunology
Sacituzumab Tirumotecan in EGFR-TKI–Resistant NSCLC (OptiTROP-Lung04 phase 3 trial) nej.md/493hVjl
Osimertinib plus Chemotherapy in 𝘌𝘎𝘍𝘙-Mutated NSCLC (FLAURA2 phase 3 trial) nej.md/4opdBzC
Sacituzumab Tirumotecan in EGFR-TKI–Resistant NSCLC (OptiTROP-Lung04 phase 3 trial) nej.md/493hVjl
Osimertinib plus Chemotherapy in 𝘌𝘎𝘍𝘙-Mutated NSCLC (FLAURA2 phase 3 trial) nej.md/4opdBzC